Trial Profile
Drug-drug interaction study of RDEA806 and emtricitabine/tenofovir disoproxil fumarate [Truvada].
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 21 Nov 2008
Price :
$35
*
At a glance
- Drugs RDEA 806 (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 14 Nov 2008 New trial record.
- 14 Nov 2008 Preliminary data has been presented at the 48th ICAAC/IDSA 46th Annual Meeting, according to an Ardea Biosciences media release.